Whole-Body Cryotherapy Improves Asprosin Secretion and Insulin Sensitivity in Postmenopausal Women-Perspectives in the Management of Type 2 Diabetes
Wiecek M, Szymura J, Kusmierczyk J, Lipowska M, Szygula Z
Biomolecules · 4 citations
How it was studied
- Design
- Controlled clinical trial (classified by our AI screen)
- Studied in
- People
- Main outcome
- Health markers and function
Who paid for it
- Funding
- Independent funding
- University or hospital
- University of Physical Education in Kraków (Poland)
- Government
- Ministry of Science and Higher Education under the name "Regional Initiative for Perfection" within the years 2019-2022
Based on 2 listed funder(s).
Publication
- Published
- 2023-10-31 · Biomolecules · vol. 13 · issue 11 · p. 1602
- Publisher
- Multidisciplinary Digital Publishing Institute
- Cited
- 6 citations · more than 69% of similar papers · 0.6× the field average
- References
- 39 works
- Access
- Open access (journal) · CC-BY
- Research areas
- Exercise and Physiological Responses · Adipose Tissue and Metabolism · Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- Type 2 diabetes, Postmenopausal women, Cryotherapy, Insulin sensitivity, Medicine, Internal medicine, Endocrinology, Diabetes mellitus, Insulin, Diabetes management, Insulin resistance, Surgery
- MeSH
- humans, diabetes mellitus, type 2, insulin resistance, insulin, glucose, blood glucose, c-reactive protein, cryotherapy, postmenopause, female, glycated hemoglobin
5 authors
From PL
- Magdalena Więcek · correspondingUniversity of Physical Culture in Kraków
- Jadwiga SzymuraUniversity of Physical Culture in Kraków
- Justyna KuśmierczykUniversity of Physical Culture in Kraków
- Maria LipowskaUniversity of Physical Culture in Kraków
- Zbigniew SzygułaUniversity of Physical Culture in Kraków
Abstract
Type 2 diabetes (T2DM) is a global problem. The effect of whole-body cryotherapy (WBC) on metabolism in humans is postulated. The aim of this study was to determine the effect of WBC on asprosin concentrations, glucose homeostasis and insulin resistance in postmenopausal women with T2DM. Changes in fasting blood glucose (FBG), glycated haemoglobin (HbA1c), insulin, asprosin, insulin-resistance indices (HOMA-IR, Quicki), the triglyceride-glucose index (TyG) and C-reactive protein (CRP) were determined. Determination was carried out after 30 WBCs (3 min, -120 °C), applied in six series of five treatments, with 2-day breaks in postmenopausal women with T2DM and the results were compared to changes in postmenopausal women without T2DM (CON). Blood was collected before 1 WBC (T0), after 30 WBCs (T1) and 2 weeks after their completion (T2). In the T2DM group, there was a significant decrease in FBG and HbA1c in T1 and T2, as well as a significant decrease in insulin, HOMA-IR and CRP, and an increase in the Quicki index in T2. In the CON group, the concentration of asprosin at T2 was significantly lower than at T0. There was a significantly positive correlation between asprosin and FBG and HOMA-IR, and a trend towards a decrease of asprosin concentration in T2 in postmenopausal women with T2DM.
Abstract via Europe PMC. Copyright remains with the authors or publisher.
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.